Role of intelligent/interactive qualitative and quantitative analysis-three-dimensional estimated model in donor-recipient size mismatch following deceased donor liver transplantation

Table 3 Univariate and multivariate logistic regression to predict early allograft dysfunction

	EAD caused by SFSS						EAD caused by LFSS
	Univariate			Multivariate			Univariate			Multivariate
	OR	95%CI	P value	OR	95%CI	P value	OR	95%CI	P value	OR	95%CI	P value
Recipient age	0.980	0.948-1.013	0.235			0.992	1.062	1.014-1.113	0.012			0.069
Male	1.268	0.433-3.715	0.665			0.357	0.295	0.109-0.800	0.016			0.134
sTLVi ≤ 0.85/≥ 1.32	175.4	21.85-1407	< 0.001	21234	126-3585713	< 0.001	100.3	16.06-970.4	< 0.001	78.56	9.529-648.0	< 0.001
Donor age	0.992	0.961-1.025	0.645				1.003	0.967-1.040	0.887
MD-FR combination	0.504	0.139-1.833	0.298				10.61	3.693-30.47	< 0.001	6.540	1.617-26.45	0.008
FD-MR combination	0.916	0.242-3.464	0.897				1.923	0.557-6.637	0.301
Graft steatosis (< 60%)	0.065	0.009-0.502	0.009			0.444	2.424	0.923-6.368	0.072
Cold ischemia time	0.923	0.725-1.174	0.512				1.006	0.772-1.312	0.962
DRI	2.376	0.859-6.573	0.095			0.086	1.069	0.346-3.305	0.908
HBV/HCV positive graft	0.163	0.021-1.271	0.083				2.420	0.817-7.174	0.111
HBV/HCV	0.361	0.149-0.877	0.025	0.095	0.010-0.919	0.042	1.058	0.391-2.862	0.912
ALD	0.838	0.259-2.712	0.768				1.649	0.535-5.084	0.384
DILF	3.607	1.040-12.51	0.043			0.979	0.488	0.059-4.005	0.504
Hepatic carcinoma	0.480	0.167-1.381	0.173				0.493	0.154-1.579	0.234
Hepatic encephalopathy	1.739	0.667-4.534	0.258				3.384	1.249-9.167	0.016			0.186
History of ALSS	2.475	0.957-6.400	0.062				1.677	0.581-4.842	0.339
Child-Pugh grade C	18.85	2.408-147.5	0.005			0.319	2.200	0.563-8.598	0.257
MELD score	1.082	1.035-1.133	0.001	1.333	1.109-1.602	0.002	1.024	0.978-1.073	0.305
Anhepatic phase time	0.949	0.893-1.009	0.097				1.049	1.000-1.100	0.050			0.808

OR: Odds ratio; 95%CI: 95% confidence interval; sTLVi: Standard total liver volume index; MD-FR: Male donor-female recipient; FD-MR: Female donor-male recipient; DRI: Donor risk index; HBV: Hepatitis B virus; HCV: Hepatitis C virus; ALD: Alcoholic liver disease; DILF: Drug-induced liver failure; PT: Prothrombin time; MELD: Model for end-stage liver disease.